Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications

Osong Public Health and Research Perspectives
Mohammad HaghighatpanahSurulivelrajan Mallayasamy

Abstract

Inadequate glycemic control amongst patients with Type 2 diabetes mellitus (T2DM) indicates a major public health problem and a significant risk factor for the progression and complications caused by diabetes. Glycemic control is the main therapeutic objective for the prevention of organ damage and other complications arising from diabetes. This was a retrospective observational study of T2DM patients with complications, who were aged 40 years and older. The study was conducted retrospectively on medical records (in-patient and out-patient) obtained from a South Indian teaching hospital, Manipal, India. The patients included in the study had fasting blood sugar, postprandial blood sugar and HbA1c measured at least twice during follow-ups the previous year. Patients' HbA1c levels were categorized into good control ≤7% (≤53mmol/mol), and poor control >7% (>53mmol/mol), and patients' characteristics were analyzed. A total of 657 patients were included in the study. The mean age was 59.67 (SD = 9.617) years, with 152 (23.1%) females and 505 (76.9%) males, and 514 (78.2%) patients had poor glycemic control. Most of the patients were on insulin mono-therapy [n = 271 (42.1%)], about a third of the patients were on combination therapy ...Continue Reading

References

Oct 11, 1990·The New England Journal of Medicine·M L LarsenE F Mogensen
Feb 4, 1998·Archives of Internal Medicine·B Gaster, I B Hirsch
Jun 27, 2000·Diabetes Care·C L RohlfingD E Goldstein
Jun 29, 2000·QJM : Monthly Journal of the Association of Physicians·T M Wallace, D R Matthews
Sep 6, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·S BoG Pagano
Jun 14, 2001·Archives of Internal Medicine·I M El-KebbiL S Phillips
Apr 16, 2003·Journal of the American Geriatrics Society·Arlene F BrownUNKNOWN California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes
Jul 2, 2003·American Journal of Ophthalmology·Lloyd M Aiello
May 27, 2004·Diabetes Care·Andrew J M BoultonJay M Sosenko
Jun 24, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·S L Jeffcoate
Mar 31, 2005·The Diabetes Educator·Mary K RheeLawrence S Phillips
Mar 21, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·C M BennettS C Dharmage
May 12, 2007·International Journal of Clinical Practice·H E BaysUNKNOWN SHIELD Investigators' Group
May 19, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·A SchweizerS Dejager
Sep 19, 2007·Annals of Internal Medicine·Amir QaseemUNKNOWN Clinical Efficacy Assessment Subcommittee of the American College of Physicians
Mar 14, 2009·Journal of Diabetes and Its Complications·Maysaa KhattabKamel Ajlouni
Apr 29, 2009·BMC Endocrine Disorders·Athanasia PapazafiropoulouStavros Pappas
Nov 13, 2009·Diabetes Care·Louis Monnier, Claude Colette
Jan 4, 2013·Diabetes Care·UNKNOWN American Diabetes Association
May 16, 2014·Canadian Journal of Diabetes·S Ali ImranStuart Ross
Feb 26, 2014·The Australasian Medical Journal·Seema Abhijeet Kaveeshwar, Jon Cornwall
Oct 4, 2014·Journal of Basic and Clinical Pharmacy·Akshay A AgarwalYeshwant A Deshmukh
Jan 5, 2016·The Journal of Clinical Investigation·Varman T Samuel, Gerald I Shulman
Mar 25, 2016·North American Journal of Medical Sciences·Satyajeet RoyJohn P Gaughan

❮ Previous
Next ❯

Citations

Nov 26, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Tsegaye MelakuKabaye Kumela
Mar 13, 2021·BioMed Research International·Luu Quang ThuyNguyen Hoang Thanh
Jun 5, 2021·Journal of Pharmacy & Bioallied Sciences·Amer Hayat KhanAhmed A Albassam
Jun 4, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Mohammed Abdu Seid, Baye Dagnew
Jul 23, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Tewodros YosefEyob Tekalign

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.